Shanghai OPM Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	891.14	1,282	1,506	310.34
Short-Term Investments	-	86.14	52.64	40.07	40.17
Trading Asset Securities	-	358.08	148.75	170.71	-
Cash & Short-Term Investments	1,371	1,335	1,484	1,717	350.51
Cash Growth	2.70%	-9.99%	-13.57%	389.76%	13.37%
Accounts Receivable	-	110.85	96.35	76.81	41.75
Other Receivables	-	8.57	-	8.04	-
Receivables	-	119.42	96.35	84.85	41.75
Inventory	-	59.12	49.21	44.01	33.72
Prepaid Expenses	-	-	-	10.55	-
Other Current Assets	-	35.18	30.17	12.66	15.2
Total Current Assets	-	1,549	1,659	1,869	441.18
Property, Plant & Equipment	-	376.42	296.92	264.04	142.83
Long-Term Investments	-	264.58	239.73	143.73	68.09
Other Intangible Assets	-	37.68	39.21	40.33	42.46
Long-Term Deferred Tax Assets	-	3.58	2.08	0.84	0.13
Long-Term Deferred Charges	-	52.06	60.3	21.52	25.38
Other Long-Term Assets	-	2.84	4.43	8.53	27
Total Assets	-	2,286	2,302	2,348	747.08
Accounts Payable	-	62.8	37.46	21.31	13.75
Accrued Expenses	-	19.58	18.08	19.91	15.66
Short-Term Debt	-	-	-	20.02	40.04
Current Portion of Long-Term Debt	-	-	-	4.31	2.13
Current Portion of Leases	-	13.02	8.6	6.45	5.27
Current Income Taxes Payable	-	4.42	0.62	-	1.63
Current Unearned Revenue	-	15.57	4.28	16.04	16.62
Other Current Liabilities	-	4.03	1.6	1.21	0.72
Total Current Liabilities	-	119.42	70.65	89.26	95.82
Long-Term Debt	-	-	-	10.86	17.77
Long-Term Leases	-	52.32	60.79	50.15	56.51
Long-Term Unearned Revenue	-	17.89	12.18	12.54	14.53
Long-Term Deferred Tax Liabilities	-	1.33	0.59	0.26	-
Total Liabilities	-	190.97	144.21	163.07	184.62
Common Stock	-	114.77	114.77	81.98	61.49
Additional Paid-In Capital	-	1,904	1,899	1,925	428.34
Retained Earnings	-	128.58	158.74	178	72.63
Treasury Stock	-	-51	-13.75	-	-
Comprehensive Income & Other	-	0.24	0.19	0.12	-
Total Common Equity	2,101	2,097	2,159	2,185	562.45
Minority Interest	-	-1.47	-0.78	-	-
Shareholders' Equity	2,100	2,095	2,158	2,185	562.45
Total Liabilities & Equity	-	2,286	2,302	2,348	747.08
Total Debt	58.66	65.34	69.39	91.8	121.72
Net Cash (Debt)	1,313	1,270	1,414	1,625	228.79
Net Cash Growth	3.37%	-10.20%	-12.96%	610.20%	-16.88%
Net Cash Per Share	11.65	10.86	12.30	16.04	2.65
Filing Date Shares Outstanding	113.82	113.55	113.91	114.77	86.08
Total Common Shares Outstanding	113.82	113.55	114.53	114.77	86.08
Working Capital	-	1,430	1,589	1,780	345.36
Book Value Per Share	18.51	18.47	18.85	19.03	6.53
Tangible Book Value	2,065	2,059	2,119	2,144	519.99
Tangible Book Value Per Share	18.19	18.13	18.51	18.68	6.04
Buildings	-	63.8	63.8	63.8	27.17
Machinery	-	230.6	200.88	128.56	112.33
Construction In Progress	-	169.33	78.1	103.47	1.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.